+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2014-06-26Number of Pages: 100

Circulating Tumor Cells (CTCs) Prognostic Technologies Market - Technologies: Tumor Cell Enrichment (Filtration, Centrifugation and Immunological & Immunomagnetic Methods) & Tumor Cell Detection (Molecular Methods and Optical Methods) and Applications: Prostate Cancer, Breast Cancer, Colorectal Cancer and Others - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

 
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global CTCs Prognostic Technologies Market
2.2 Comparative Analysis: Global CTCs Prognostic Technologies Market, by Geography, 2013 & 2020 (Value %)
 
Chapter 3 Global CTCs Prognostic Technologies Market Overview
3.1 Market Dynamics and Overview
3.1 Market Drivers
      3.1.1 Escalating Prevalence Rate of Cancer
      3.1.2 High Cost-benefit Ratio
      3.1.3 Increased Evaluation of Therapeutic Monitoring
      3.1.4 Technological Development
3.2 Market Restraints
      3.2.1 High Pricing Associated with CTCs Detection
      3.2.2 Lack of Specificity and Sensitivity
      3.2.3 Reluctance in Adopting Advanced Prognostic Technologies 
3.3 Market Opportunities
      3.3.1 Strengthening Distribution Network In Emerging Markets
      3.3.2 Development of Personalized Medicines based on CTCs
3.4 Porter’s Five Forces Analysis
      3.4.1 Bargaining Power of Suppliers
      3.4.2 Bargaining Power of Buyers
      3.4.3 Threat of Substitutes
      3.4.4 Threat of New Entrants
      3.4.5 Competitive Rivalry
3.5 Event Impact Analysis (Historical Trends and Future Outlook), 2012 – 2020
3.6 Market Attractiveness Analysis of Global CTCs Prognostic Technologies Market, by Geography
3.7 Competitive Landscape
      3.7.1 Global Market Share Analysis, by Key Players, Global CTCs Prognostic Technologies Market, 2013 (Value %)
 
Chapter 4 Global CTCs Prognostic Technologies Market, by Technology
4.1 Overview
4.2 Tumor Cell Enrichment
      4.2.1 Global Tumor Cell Enrichment Market Revenue, 2012 – 2020 (USD Million)
      4.2.2 Filtration
               4.2.2.1 Global Tumor Cell Enrichment by Filtration Market Revenue, 2012 – 2020 (USD Million)
      4.2.3 Centrifugation
               4.2.3.1 Global Tumor Cell Enrichment by Centrifugation Market Revenue, 2012 – 2020 (USD Million)
      4.2.4 Immunological and Immunomagnetic Methods
               4.2.4.1 Global Tumor Cell Enrichment by Immunological and Immunomagnetic Methods Market Revenue, 2012 – 2020 (USD Million)
4.3 Tumor Cell Detection
      4.3.1 Global Tumor Cell Detection Market Revenue, 2012 – 2020 (USD Million)
      4.3.2 Molecular Methods
               4.3.2.1 Global Tumor Cell Detection by Molecular Methods Market Revenue, 2012 – 2020 (USD Million)
      4.3.3 Optical Methods
               4.3.3.1 Global Tumor Cell Detection by Optical Methods Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 5 Global CTCs Prognostic Technologies Market, by Applications
5.1 Overview
      5.1.1 Global CTCs Prognostic Technologies Market Revenue, by Applications, 2012 – 2020 (USD Million)
5.2 Prostate Cancer
      5.2.1 Global CTCs Application in Prostate Cancer Market Revenue, 2012 – 2020 (USD Million)
5.3 Breast Cancer
      5.3.1 Global CTCs Application in Breast Cancer Market Revenue, 2012 – 2020 (USD Million)
5.4 Colorectal Cancer
      5.4.1 Global CTCs Application in Colorectal Cancer Market Revenue, 2012 – 2020 (USD Million)
5.5 Others (Lung Cancer, Ovarian Cancer and Pancreatic Cancer)
      5.5.1 Global CTCs Application in Other Cancer Types Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 6 Global CTCs Prognostic Technologies Market, by Geography
6.1 Overview
      6.1.1 Global CTCs Prognostic Technologies Market Revenue, by Geography, 2012 – 2020 (USD Million)
6.2 North America
      6.2.1 North America CTCs Prognostic Technologies Market Revenue, 2012 – 2020 (USD Million)
6.3 Europe
      6.3.1 Europe CTCs Prognostic Technologies Market Revenue, 2012 – 2020 (USD Million)
6.4 Asia-Pacific
      6.4.1 Asia-Pacific CTCs Prognostic Technologies Market Revenue, 2012 – 2020 (USD Million)
6.5 Rest of the World (RoW)
      6.5.1 RoW CTCs Prognostic Technologies Market Revenue, 2012 – 2020 (USD Million)
 
Chapter 7 Recommendations
 
Chapter 8 Company Profiles
8.1 AdnaGen GmbH
      8.1.1 Company Overview
      8.1.2 Financial Overview
      8.1.3 Product Portfolio
      8.1.4 Business Strategies
      8.1.5 Recent Developments
8.2 Advanced Cell Diagnostics, Inc.
      8.2.1 Company Overview
      8.2.2 Financial Overview
      8.2.3 Product Portfolio
      8.2.4 Business Strategies
      8.2.5 Recent Developments
8.3 AVIVA Biosciences Corporation
      8.3.1 Company Overview
      8.3.2 Financial Overview
      8.3.3 Product Portfolio
      8.3.4 Business Strategies
8.4 Celula, Inc.
      8.4.1 Company Overview
      8.4.2 Financial Overview
      8.4.3 Product Portfolio
      8.4.4 Business Strategies
8.5 Epic Sciences, Inc.
      8.5.1 Company Overview
      8.5.2 Financial Overview
      8.5.3 Product Portfolio
      8.5.4 Business Strategies
      8.5.5 Recent Developments
8.6 Fluxion Biosciences, Inc.
      8.6.1 Company Overview
      8.6.2 Financial Overview
      8.6.3 Product Portfolio
      8.6.4 Business Strategies
      8.6.5 Recent Developments
8.7 Rarecells USA, Inc.
      8.7.1 Company Overview
      8.7.2 Financial Overview
      8.7.3 Product Portfolio
      8.7.4 Business Strategies
8.8 Silicon Biosystems, S.p.A.
      8.8.1 Company Overview
      8.8.2 Financial Overview
      8.8.3 Product Portfolio
      8.8.4 Business Strategies
      8.8.5 Recent Developments
8.9 Vitatex, Inc.
      8.9.1 Company Overview
      8.9.2 Financial Overview
      8.9.3 Product Portfolio
      8.9.4 Business Strategies
8.10 Veridex, LLC
      8.10.1 Company Overview
      8.10.2 Financial Overview
      8.10.3 Product Portfolio
      8.10.4 Business Strategies
      8.10.5 Recent Developments

List of Figures
 
FIG. 1 CTCs Prognostic Technologies: Market Segmentation
FIG. 2 Global CTCs Prognostic Technologies Market, by Technology, 2012 (USD Million)
FIG. 3 Global CTCs Prognostic Technologies Market, by Applications, 2012 (USD Million)
FIG. 4 Comparative Analysis: CTCs Prognostic Technologies Market, by Geography, 2013 & 2020 (Value %)
FIG. 5 Circulating Tumor Cells (CTCs) Prognostic Technologies Market: Drivers and Restraints
FIG. 6 Porter’s Five Forces Analysis: Circulating Tumor Cells (CTCs) Prognostic Technologies Market
FIG. 7 Market Attractiveness Analysis: Global CTCs Prognostic Technologies Market, by Geography
FIG. 8 Market Share by Key Players: Global CTCs Prognostic Technologies Market, 2013 (Value %)
FIG. 9 Global Tumor Cell Enrichment by Filtration Market Revenue, 2012 – 2020 (USD Million)
FIG. 10 Global Tumor Cell Enrichment by Centrifugation Market Revenue, 2012 – 2020 (USD Million)
FIG. 11 Global Tumor Cell Enrichment by Immunological and Immunomagnetic Methods Market Revenue, 2012 – 2020 (USD Million)
FIG. 12 Global Tumor Cell Detection by Molecular Methods Market Revenue, 2012 – 2020 (USD Million)
FIG. 13 Global Tumor Cell Detection by Optical Methods Market Revenue, 2012 – 2020 (USD Million)
FIG. 14 Global CTCs Application in Prostate Cancer Market Revenue, 2012 – 2020 (USD Million)
FIG. 15 Global CTCs Application in Breast Cancer Market Revenue, 2012 – 2020 (USD Million)
FIG. 16 Global CTCs Application in Colorectal Cancer Market Revenue, 2012 – 2020 (USD Million)
FIG. 17 Global CTCs Application in Other Cancer Types Market Revenue, 2012 – 2020 (USD Million)
FIG. 18 North America CTCs Prognostic Technologies Market Revenue, 2012 – 2020 (USD Million)
FIG. 19 Europe CTCs Prognostic Technologies Market Revenue, 2012 – 2020 (USD Million)
FIG. 20 Asia-Pacific CTCs Prognostic Technologies Market Revenue, 2012 – 2020 (USD Million)
FIG. 21 RoW CTCs Prognostic Technologies Market Revenue, 2012 – 2020 (USD Million)
FIG. 22 Alere, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 23 Menarini Group: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 24 Johnson & Johnson: Annual Revenue, 2011 – 2013 (USD Million)

List of Tables
 
TABLE 1 Market Snapshot: Global CTCs Prognostic Technologies Market
TABLE 2 Global CTCs Prognostic Technologies Market Revenue, by Technology, 2012 – 2020 (USD Million)
TABLE 3 Global Tumor Cell Enrichment Market Revenue, 2012 – 2020 (USD Million)
TABLE 4 Global Tumor Cell Detection Market Revenue, 2012 – 2020 (USD Million)
TABLE 5 Global CTCs Prognostic Technologies Market Revenue, by Applications, 2012 – 2020 (USD Million)
TABLE 6 Global CTCs Prognostic Technologies Market Revenue, by Geography, 2012 – 2020 (USD Million)


 
 
Back To Top